LON:EDENEden Research Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Eden Research plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 6.57 +0.20 (+3.14 %) (As of 06/1/2020 06:02 AM ET) Add Compare Share Today's Range 6.57Now: GBX 6.57▼ 6.9950-Day Range 0.07MA: GBX 6.74▼ 7.5052-Week Range 4.43Now: GBX 6.57▼ 11.64Volume90,039 shsAverage Volume70,119 shsMarket Capitalization£24.99 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsInsider TradesHeadlines Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides various plant protection products, such as foliar disease control, soil pest, protected glass house crops, and post-harvest applications. It also offers treatment for various pathogens that effect animal health, as well as provides animal health products, such as shampoos, conditioners, odour controls, flea and tick controls, hygiene products, parasite treatments, and insect sprays. In addition, the company offers human health products comprising head-lice, fragrances, wound-care, and food flavorings. Further, it provides a range of natural and synthetic active ingredients, including pesticides, as well as biocides. The company was incorporated in 1995 and is headquartered in Cirencester, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Eden Research. Previous Next 2.4 Community Rank Outperform VotesEden Research has received 115 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEden Research has received 126 “underperform” votes. (Add your “underperform” vote.)Community SentimentEden Research has received 52.28% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Eden Research and other stocks. Vote “Outperform” if you believe EDEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EDEN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEden Research does not currently pay a dividend.Dividend GrowthEden Research does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Eden Research insiders have bought more of their company's stock than they have sold. Specifically, they have bought £382,570 in company stock and sold GBX 0 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Eden Research is -13.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Eden Research is -13.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEden Research has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.08 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Agricultural Chemicals Sub-IndustryN/A SectorBasic Materials Current SymbolLON:EDEN Previous Symbol CUSIPN/A CIKN/A Webwww.edenresearch.com Phone+44-1285-359555Debt Debt-to-Equity Ratio0.95 Current Ratio1.80 Quick Ratio1.64Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£2.05 million Price / Sales12.20 Cash FlowGBX 0.21 per share Price / Cash Flow31.75 Book ValueGBX 3.50 per share Price / Book1.88Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees5 Outstanding Shares380,340,000Market Cap£24.99 million Next Earnings DateN/A OptionableNot Optionable LSE:EDEN Rates by TradingView Receive EDEN News and Ratings via Email Sign-up to receive the latest news and ratings for EDEN and its competitors with MarketBeat's FREE daily newsletter. Eden Research (LON:EDEN) Frequently Asked Questions How has Eden Research's stock been impacted by COVID-19 (Coronavirus)? Eden Research's stock was trading at GBX 6.15 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EDEN stock has increased by 6.8% and is now trading at GBX 6.57. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Eden Research? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eden Research in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Eden Research. Has Eden Research been receiving favorable news coverage? News coverage about EDEN stock has trended negative on Monday, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Eden Research earned a news sentiment score of -2.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutEden Research. Who are some of Eden Research's key competitors? Some companies that are related to Eden Research include Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET), SenesTech (SNES), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT) and ICL Group (ICL). View all competitors. What other stocks do shareholders of Eden Research own? Based on aggregate information from My MarketBeat watchlists, some companies that other Eden Research investors own include Kromek Group (KMK), Primary Health Properties (PHP), Cabot Energy (CAB), National Grid (NG), Ophir Energy (OPHR), Gigamon (GIMO), Marston's (MARS), Mothercare (MTC), Synopsys (SNPS) and AFC Energy (AFC). Who are Eden Research's key executives? Eden Research's management team includes the following people: Mr. Sean M. Smith, CEO & DirectorMr. Alexander John Abrey, CFO, Sec. & Director What is Eden Research's stock symbol? Eden Research trades on the London Stock Exchange (LON) under the ticker symbol "EDEN." How do I buy shares of Eden Research? Shares of EDEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Eden Research's stock price today? One share of EDEN stock can currently be purchased for approximately GBX 6.57. How big of a company is Eden Research? Eden Research has a market capitalization of £24.99 million and generates £2.05 million in revenue each year. Eden Research employs 5 workers across the globe. What is Eden Research's official website? The official website for Eden Research is www.edenresearch.com. How can I contact Eden Research? Eden Research's mailing address is Priory Crt Business Park, 6 Priory Court, CIRENCESTER, GL7 5JB, United Kingdom. The company can be reached via phone at +44-1285-359555. This page was last updated on 6/1/2020 by MarketBeat.com Staff
